From left to right: Lou Tartaglia, Richard Lim and Dave Fallace (Cure Ventures)
The ‘new, old kids’ on the biotech block unveil a $350M stealth science fund. And they’re going very, very early
Richard Lim and his two co-founders at Cure Ventures have some biotech stories to tell.
Lim recalls the time some 17 years ago he and …
This article is available only to Premium subscribers
Upgrade to Premium for unlimited access and Premium exclusives.
